Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-03-20 @ 9:01 AM
Study NCT ID:
NCT04230304
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-03
First Post:
2020-01-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study
Sponsor:
Organization: